2018
DOI: 10.1126/sciadv.aau4602
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing a previously unidentified capability of bacterial allosteric transcription factors for sensing diverse small molecules in vitro

Abstract: We develop a novel biosensing platform for the detection of diverse small molecules.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(25 citation statements)
references
References 75 publications
0
25
0
Order By: Relevance
“…5c). CaT-SMelor has many unique advantages over previous aTF-based and protein-immobilization-assisted methods of small-molecule detection 4,5, (Table 1) and has great potential utility in the future development of a miniature portable device for the detection of small molecules or disease diagnoses.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…5c). CaT-SMelor has many unique advantages over previous aTF-based and protein-immobilization-assisted methods of small-molecule detection 4,5, (Table 1) and has great potential utility in the future development of a miniature portable device for the detection of small molecules or disease diagnoses.…”
Section: Discussionmentioning
confidence: 99%
“…The presence and binding of the target molecule usually induces a conformational change in the aTF DNA-binding domain, which then enhances or attenuates the double-stranded DNA (dsDNA)-binding capacity of the aTF by the direct binding of the aTF effector-binding domain 1 . Recently, we developed a bacterial-aTF-based in vitro biosensing platform, aTF-NAST (aTF-based nicked DNA-template-assisted signal transduction) by exploiting the competition between T4 DNA ligase and aTFs in binding to nicked DNA 4,5 . However, this is a relatively time-consuming, inconvenient and costly method of detecting small molecules.…”
Section: Introductionmentioning
confidence: 99%
“…Only very recently have aTFs been examined as biomolecular recognition elements for in vitro sensing. [ 10,28–31 ] Of the limited number of signal transduction mechanisms explored, only ours utilizes FRET. One homogeneous assay achieved nanomolar sensing using an amplified luminescent proximity homogeneous assay (AlphaScreen).…”
Section: Figurementioning
confidence: 99%
“…[ 28,31 ] Two other assay designs provide only an indirect measure of aTF–DNA binding by amplifying and quantifying (un)bound DNA. [ 29–31 ] Using existing methods of DNA detection facilitates incorporation into existing workflows but lacks the advantages of a real‐time, homogeneous assay without substantial gains in the LOD or linear dynamic range. [ 29–31 ] Our FRET‐based sensor maintains the rapidity and convenience of the homogeneous assay, while incorporating a ratiometric output and widely accessible fluorophores to facilitate broader adoption.…”
Section: Figurementioning
confidence: 99%
“…Besides signal recognition, signal transduction is also an essential aspect for the development of biosensors. Various biosensing systems, including CRISPR-Cas12a-and allosteric transcription factors-mediated small molecule detector39 , allosteric transcription factors-based nicked DNA-template-assisted signal transduction40 , and quantum-dotallosteric transcription factors-FRET41 , have been reported. Other biosensors based on L-2-HG responding to LhgR and the corresponding transduction mechanisms could also be developed for detection of L-2-HG.…”
mentioning
confidence: 99%